Company Filing History:
Years Active: 1976
Title: Balthasar Hegedus: Innovator in Cytostatic Agents
Introduction
Balthasar Hegedus is a notable inventor based in Binningen, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as cytostatic agents. His work has implications for cancer treatment and other medical applications.
Latest Patents
Hegedus holds a patent for "Methylhydrazinomethyl-substituted benzoic acid amides." This patent describes benzene-ring substituted (2-methylhydrazino)methylbenzene compounds and their intermediates. The compounds outlined in his patent are recognized for their utility as cytostatic agents, showcasing Hegedus's innovative approach to drug development.
Career Highlights
Balthasar Hegedus is associated with Hoffmann-La Roche Inc., a leading global healthcare company. His role at the company has allowed him to work on groundbreaking research and development projects. Hegedus's expertise in medicinal chemistry has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Throughout his career, Hegedus has collaborated with esteemed colleagues such as Werner Bollag and Hugo Gutmann. These partnerships have fostered an environment of innovation and have contributed to the advancement of research in the field.
Conclusion
Balthasar Hegedus is a distinguished inventor whose work in developing cytostatic agents has the potential to impact medical treatments significantly. His contributions to the field of medicinal chemistry continue to inspire future innovations.